The historical rank and industry rank for Osteopore's EV-to-EBIT or its related term are showing as below:
ASX:OSX'
s EV-to-EBIT Range Over the Past 10 Years
Min: -24.32 Med: -5.11 Max: -0.66
Current: -1.82
During the past 6 years, the highest EV-to-EBIT of Osteopore was -0.66. The lowest was -24.32. And the median was -5.11.
ASX:OSX's EV-to-EBIT is ranked worse than 100% of 458
companies
in the Medical Devices & Instruments industry
Industry Median: 20.815
vs ASX:OSX: -1.82
The historical data trend for Osteopore's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Osteopore's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osteopore's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Osteopore's EV-to-EBIT falls into.
Osteopore EV-to-EBIT Calculation
Osteopore's EV-to-EBIT for today is calculated as:
Osteopore's current Enterprise Value is A$8.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Osteopore's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-4.81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Osteopore (ASX:OSX) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Osteopore's Enterprise Value for the quarter that ended in Dec. 2023 was A$6.89 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Osteopore's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-4.81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Osteopore EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Osteopore's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Osteopore Ltd is engaged in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:OSX has been successfully added to your 